#21061
Re: Novavax (NVAX): Un Nuevo Comienzo
estupendo, me pilla bien de agenda, el Lunes me va bien.
Ademas que el mercado lo sepa con cierta antelacion favorece posibilidad de rally pre-news.
Novavax: Looking At A Monster Rise In Revenues In 2022
If everything goes well, over the next year, revenues will go from $18.66 million for the full year in 2019 to $4.83 billion in full year revenues in 2022, making this stock a buy.